HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

Plant-Based Vaccines

Plant-Based Vaccines

Plant-based vaccines represent an innovative approach to vaccine development, utilizing plants as bioreactors for producing antigens. This method harnesses the natural ability of plants to synthesize complex proteins, enabling the mass production of vaccine components that can stimulate an immune response. Plant-derived vaccines offer several advantages, including ease of production, cost-effectiveness, and stability at ambient temperatures, which is crucial for distribution in developing regions. Additionally, the use of plants minimizes the risk of contamination associated with traditional vaccine production methods. Research is ongoing to optimize the efficacy and delivery of these vaccines, with the potential to combat diseases in both humans and animals.

Committee Members
Speaker at GPB 2027 - K R Aneja

K R Aneja

Kurukshetra University, India
Speaker at GPB 2027 - Mary Cole

Mary Cole

The University of Melbourne, Australia
Speaker at GPB 2027 - Mohammad Babadoost

Mohammad Babadoost

University of Illinois, United States
GPB 2027 Speakers
Akkalareddy Sumalatha

Akkalareddy Sumalatha

ICAR-Indian Agricultural Research Institute, India
Amit Kumar

Amit Kumar

CSIR-Institute of Himalayan Bioresource Technology, India
Indira Rathore

Indira Rathore

ICAR-Indian Agricultural Research Institute, India

Submit your abstract Today

WhatsApp